Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin
- PMID: 15571611
- DOI: 10.1111/j.1048-891X.2004.14603.x
Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin
Abstract
To determine whether ginger had antiemetic effect in cisplatin-induced emesis, we conducted a randomized, double-blinded crossover study in 48 gynecologic cancer patients receiving cisplatin-based chemotherapy. Subjects were randomly allocated to regimen A or regimen B in their first cycle of the study. All patients received standard antiemetics in the first day of cisplatin administration. In regimen A, capsules of ginger root powder were given orally 1 g /day for 5 days, starting on the first day of chemotherapy. In regimen B, placebo was given on the first day and metoclopramide was given orally thereafter for 4 days. The patients were then crossed over to receive the other antiemetic regimen in their next cycle of chemotherapy. Among 43 evaluable patients who received both cycles of treatment, success in controls of nausea and emesis were not significantly different between the two regimens in both acute and delayed phases. Restlessness, as a side effect, occurred more often in metoclopramide arm compared to ginger arm (P=0.109). In conclusion, addition of ginger to standard antiemetic regimen has no advantage in reducing nausea or vomiting in acute phase of cisplatin-induced emesis. In delayed phase, ginger and metoclopramide have no statistically significant difference in efficacy.
Similar articles
-
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.Support Care Cancer. 2017 Feb;25(2):459-464. doi: 10.1007/s00520-016-3423-8. Epub 2016 Oct 6. Support Care Cancer. 2017. PMID: 27714530 Clinical Trial.
-
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients.Support Care Cancer. 2012 Jul;20(7):1479-89. doi: 10.1007/s00520-011-1236-3. Epub 2011 Aug 5. Support Care Cancer. 2012. PMID: 21818642 Free PMC article. Clinical Trial.
-
Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial.Integr Cancer Ther. 2012 Sep;11(3):204-11. doi: 10.1177/1534735411433201. Epub 2012 Feb 7. Integr Cancer Ther. 2012. PMID: 22313739 Clinical Trial.
-
Ginger as an antiemetic modality for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.Oncol Nurs Forum. 2013 Mar;40(2):163-70. doi: 10.1188/13.ONF.163-170. Oncol Nurs Forum. 2013. PMID: 23448741 Review.
-
[Recent improvements in antiemetic therapy].Tumori. 1997;83(2 Suppl):S3-14. Tumori. 1997. PMID: 9235727 Review. Italian.
Cited by
-
Cisplatin-induced gastric dysrhythmia and emesis in dogs and possible role of gastric electrical stimulation.Dig Dis Sci. 2009 May;54(5):922-7. doi: 10.1007/s10620-008-0470-0. Epub 2008 Aug 27. Dig Dis Sci. 2009. PMID: 18754094
-
The Influence of Oral Ginger before Operation on Nausea and Vomiting after Cataract Surgery under General Anesthesia: A double-blind placebo-controlled randomized clinical trial.Electron Physician. 2017 Jan 25;9(1):3508-3514. doi: 10.19082/3508. eCollection 2017 Jan. Electron Physician. 2017. PMID: 28243400 Free PMC article.
-
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.Support Care Cancer. 2017 Feb;25(2):459-464. doi: 10.1007/s00520-016-3423-8. Epub 2016 Oct 6. Support Care Cancer. 2017. PMID: 27714530 Clinical Trial.
-
The Effects of Medicinal Plants and Bioactive Natural Compounds on Homocysteine.Molecules. 2021 May 21;26(11):3081. doi: 10.3390/molecules26113081. Molecules. 2021. PMID: 34064073 Free PMC article. Review.
-
A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy.Med Oncol. 2017 Apr;34(4):69. doi: 10.1007/s12032-017-0931-4. Epub 2017 Mar 27. Med Oncol. 2017. PMID: 28349496 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical